Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

IFN vs IBN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

IBN Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 8–2 Matrix Metrics)

IBN Overall Winner 6-Pillar Tally: IFN 0 – 5 IBN (1 Tie) Matrix Metrics: IFN 2 – 8 IBN

As of Nov 16, 2026, ICICI Bank Limited (IBN) is the stronger overall head-to-head candidate over The India Fund, Inc. (IFN) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). IFN carries a Unified Composite Score of 29.1/100 (SELL) at $11.48 (N/M Forward P/E, N/A operating margin), whereas IBN carries 26.1/100 (SELL) at $34.42 (20.3x Forward P/E, 29.9% operating margin).

  • Composite vs. Pillar Nuance: While IFN currently prints a higher short-term Unified Composite Score (29.1/100 SELL vs. IBN 26.1/100 SELL), IBN captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (29.9% vs. N/A operating margin) and revenue trajectory (+15.8% vs. N/A YoY).
  • Defensive Composite Rating Caution: Although IBN compares more favorably head-to-head, both IFN (29.1/100 SELL) and IBN (26.1/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About IFN vs IBN
IFN NYSE
The India Fund, Inc.
Institutional Equity
$11.48
+0.17% 1D
Market Cap $593.5M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.68β · 20% Vol
Unified Composite Score
29.1 / 100 SELL
Tech 5.0 Fund 33.0 Flow 50.0 Mom 54.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 70
RSI-14: 69.8 · SMA20: $10.86 · SMA50: $10.80
IBN NYSE Head-to-Head Winner
ICICI Bank Limited
Commercial Banks, Nec
$34.42
-0.29% 1D
Market Cap $123.9B
TTM Revenue $22.7B
Forward P/E 20.3x
Beta / 30D Vol 0.46β · 27% Vol
Unified Composite Score
26.1 / 100 SELL
Tech 50.0 Fund 28.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (2.1% over 20 days), RSI 76
RSI-14: 76.2 · SMA20: $31.48 · SMA50: $29.58

6-Pillar Scorecard Institutional Category Breakdown (IFN 0 – 5 IBN)

Columns: Metric · IFN · IBN
1. Valuation Multiples IBN
Forward P/E N/M 20.3x
Trailing P/E N/M 19.6x
PEG Ratio N/M 0.52x
EV / Revenue N/M 5.5x
2. Growth & Scale IBN
Revenue Growth (YoY) N/A +15.8%
Earnings Growth (YoY) N/A +22.1%
TTM Revenue (USD) N/A $22.7B
Market Cap $593.5M $123.9B
3. Profitability & Quality IBN
Gross Margin N/A 100.0%
Operating Margin N/A 29.9%
Net Profit Margin N/A 27.8%
Return on Equity (ROE) N/A 16.5%
4. Balance Sheet & Cash Flow IBN
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE $11.54 Book/Sh · 16.5% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 16.0% (1st %ile)
Put/Call OI Skew N/A Thin ADR Chain
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markup
6. R&D & Supply-Chain Moat IBN
OpEx & R&D Intensity N/A 70.1% of Rev ($15.9B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Scale & Operating Efficiency Moat
Supply-Chain Role Institutional Equity Operator Banks - Regional Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: IFN (2) vs IBN (8)
Institutional Metric IFN IBN Criterion Row Edge
Market Capitalization
Scale
$593.5M $123.9B Larger Scale IBN
Trailing P/E Ratio
Valuation
N/M 19.6x Lower Multiple IBN
Forward P/E Ratio
Valuation
N/M 20.3x Lower Multiple IBN
Revenue Growth (YoY)
Growth
N/A +15.8% Higher Growth IBN
Operating Margin (TTM)
Profitability
N/A 29.9% Higher Margin IBN
Net Profit Margin
Profitability
N/A 27.8% Higher Margin IBN
Return on Equity (ROE)
Capital Efficiency
N/A 16.5% Higher ROE IBN
52-Week Range Position
Momentum
26% ($10–$15) 94% ($25–$35) Stronger Trend IBN
Beta / 30D Volatility
Risk Regime
0.68β · 20% Vol 0.46β · 27% Vol Lower Realized Risk IFN
Unified Institutional Score
Composite Signal
29.1 / 100 (SELL) 26.1 / 100 (SELL) Higher Composite IFN
Trailing 12M Revenue (USD)
Operating Scale
N/A $22.7B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 100.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev 0.52x PEG · 5.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A ($11.54 Book/Sh · 16.5% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon IBN +6.16 pp
IFN: +8.61% · IBN: +14.77%
3M Horizon IBN +18.8 pp
IFN: -2.63% · IBN: +16.17%
6M Horizon IBN +33.96 pp
IFN: -0.86% · IBN: +33.1%
1Y Horizon IBN +35.06 pp
IFN: -23.92% · IBN: +11.14%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IFN vs IBN. Trailing 12-month operating profitability (IFN N/A vs IBN 29.9%) and valuation multiples (IFN N/M vs IBN 20.3x Forward P/E) are benchmarked directly in Pillar 4 below.

IFN ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
IBN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$22.7B
Gross Margin100.0%
Op. Margin29.9%
ROE / Fwd P/E16.5% · 20.3x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
IFN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact IFN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
IBN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 16.0%
IV Percentile 1st %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact IBN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
IFN Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with $593.5M market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
IBN Moat Profile Scale & Operating Efficiency Moat
Banks - Regional Operator
Competes within the Banks - Regional value chain with $123.9B market capitalization and 29.9% operating margin.
OpEx & R&D Reinvestment 70.1% of Rev ($15.9B)
90D Engineering Disclosures 0 Published

Investor FAQ IFN vs IBN Key Questions & Quantitative Answers

As of Nov 16, 2026, ICICI Bank Limited (IBN) is the stronger overall head-to-head candidate over The India Fund, Inc. (IFN) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). IFN carries a Unified Composite Score of 29.1/100 (SELL) at $11.48 (N/M Forward P/E, N/A operating margin), whereas IBN carries 26.1/100 (SELL) at $34.42 (20.3x Forward P/E, 29.9% operating margin). Composite vs. Pillar Nuance: While IFN currently prints a higher short-term Unified Composite Score (29.1/100 SELL vs. IBN 26.1/100 SELL), IBN captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (29.9% vs. N/A operating margin) and revenue trajectory (+15.8% vs. N/A YoY). Defensive Composite Rating Caution: Although IBN compares more favorably head-to-head, both IFN (29.1/100 SELL) and IBN (26.1/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.

IBN leads the Growth & Scale pillar: IFN posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with IBN at +15.8% YoY revenue growth and +22.1% YoY earnings growth on $22.7B TTM revenue (100.0% gross margin, 29.9% operating margin). On trailing 12-month operating scale, IFN generates N/A in USD-normalized revenue versus $22.7B for IBN. In operating R&D and SG&A reinvestment, IFN deploys N/A (0 90-day corporate R&D disclosures) versus 70.1% of Rev ($15.9B) (0 disclosures) for IBN.

IBN screens cheaper on headline valuation multiples. IFN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas IBN trades at 20.3x Forward P/E, 19.6x Trailing P/E, 0.52x PEG, and 5.5x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against IFN (N/A ROE) versus IBN (16.5% ROE) capital efficiency.

In options market volatility and institutional positioning, IFN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.68β · 20% Vol realized risk). By comparison, IBN carries 16.0% implied volatility (1st %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.46β · 27% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.